Congenital malformations concern 3% of pregnancies; most of them can be seen during pregnancy. For some malformations, an invasive sample (trophoblast biopsy or amniocentesis) is proposed to search a chromosomal abnormality by the technique of DNA chip. However, some strongly suggestive signs of a genetic (and not chromosomal) pathology have a very low diagnostic rate with this technique. In the absence of an etiological diagnosis, the prognosis for the unborn child is very difficult to assess, as we can't know if the fetal malformation is really isolated or associted to other unseen features as part of a syndromic condition. For some malformations strongly suggestive of a genetic condition, we propose to realize an exome (i.e. all coding parts of the genome) sequencing of the trio (child and the 2 parents) with a delivery time compatible with the emergency situation of a pregnancy (6 weeks maximum). We will apply bioinformatics filters to analyse only genes known to be involved in the malformation present in the unborn child and thus avoid the identification of variants in unrelated genes. These lists of genes have been previously validated by the Rare Disease Health Sectors and the affiliated diagnostic laboratories. The selected malformations are: 1) anomalies of the central nervous system (microcephaly (\<- 2DS) with anomalies of gyration, anomalies of the posterior fossa, anomalies of the midline except agenesis of the corpus callosum), 2) ophthalmological anomalies (microphthalmia, hyperplasia vitreous) and 3) renal abnormalities (large hyperechoic kidneys).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
90
A blood sample will be used for CGH-array and exome sequencing
CHu de Besançon
Besançon, France
NOT_YET_RECRUITINGCHU de Dijon
Dijon, France
NOT_YET_RECRUITINGHospices Civils de Lyon
Lyon, France
NOT_YET_RECRUITINGGroupe Hospitalier Region Mulhouse Et Sud Alsace
Mulhouse, France
NOT_YET_RECRUITINGCHU de Nancy
Nancy, France
NOT_YET_RECRUITINGHôpital d'Enfants Armand-Trousseau
Paris, France
NOT_YET_RECRUITINGHôpital de la Pitié Salpêtrière
Paris, France
NOT_YET_RECRUITINGHôpital Necker Enfants Malades
Paris, France
NOT_YET_RECRUITINGCHU de Reims
Reims, France
NOT_YET_RECRUITINGCHU de Rennes
Rennes, France
NOT_YET_RECRUITING...and 2 more locations
Diagnostic contribution of the exome sequencing in antenatal period in comparison with the chromosomal analysis (CGH-array) realized in current health care
Comparison of the number of genetic diagnoses made by exome sequencing and by CGH-array.
Time frame: 13 months
Effects on pregnancy management and/or postnatal child care due to an etiological diagnosis
Percentage of antenatal and/or postnatal fetus/child care modified by the molecular result
Time frame: 13 months
Feasibility study of carrying out exome sequencing in the antenatal period in terms of time to deliver results
Time to results from the inclusion of the trio (in days) specifying the time for each step (reception, sequencing, bioinformatics analysis, interpretation) (in days)
Time frame: 13 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.